Department of Obstetrics and Gynecology, University of Tokyo, 7-3-1 Hongo Bunkyo, Tokyo 113-8655, Japan.
Hum Reprod. 2009 Dec;24(12):3042-8. doi: 10.1093/humrep/dep297. Epub 2009 Aug 14.
The aim of this study was to evaluate the impact of post-operative oral contraceptives (OCs) use on the rate of recurrence after laparoscopic excision of ovarian endometrioma.
In May 2005, we introduced a 'post-operative OC recommendation' for patients treated with laparoscopic excision of endometrioma. That is, at the time of the operation, we provided each patient with information about OC, known and possible benefits and risks and let her decide whether to take OC. A retrospective cohort study included 87 patients who underwent a laparoscopy after May 2005. The endometrioma recurrence rate at 24 months was compared between those who used OC for the entire follow-up period OC (n = 34) and all of the others (n = 53). We also performed logistic regression analysis to identify variables associated with recurrence. A before-after study included another 224 patients who underwent a laparoscopy before May 2005 and compared the recurrence rate before and after introduction of the 'post-operative OC recommendation'.
The recurrence rate in those who used OC for the entire period was significantly lower than in the 'others' group (2.9 versus 35.8%, relative risk 0.082, 95% CI 0.012-0.58, P < 0.001). Post-operative OC was determined as an independent variable associated with lower recurrence (OR 0.054, 95% CI 0.007-0.429, P < 0.001). The overall recurrence rate in patients who underwent laparoscopy after the introduction of the 'post-operative OC recommendation' was significantly lower than that in patients who received laparoscopy before the introduction (18.6 versus 33.1%, relative risk 0.56, 95% CI 0.32-0.97, P < 0.05).
Post-operative OC use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. This information will help in appropriate planning of pre- and post-operative management.
本研究旨在评估术后口服避孕药(OC)使用对腹腔镜切除卵巢子宫内膜异位症后复发率的影响。
2005 年 5 月,我们对接受腹腔镜切除子宫内膜异位症的患者引入了“术后 OC 推荐”。即手术时,我们向每位患者提供 OC 的信息,已知和可能的益处和风险,并让她决定是否服用 OC。一项回顾性队列研究纳入了 87 例 2005 年 5 月后接受腹腔镜检查的患者。比较了整个随访期间使用 OC(n=34)和其他所有患者(n=53)的 24 个月时的内异症复发率。我们还进行了逻辑回归分析,以确定与复发相关的变量。一项前后研究纳入了 224 例 2005 年 5 月前接受腹腔镜检查的患者,并比较了“术后 OC 推荐”引入前后的复发率。
整个 OC 使用期的复发率明显低于“其他”组(2.9%对 35.8%,相对风险 0.082,95%CI 0.012-0.58,P<0.001)。术后 OC 是与较低复发率相关的独立变量(OR 0.054,95%CI 0.007-0.429,P<0.001)。引入“术后 OC 推荐”后接受腹腔镜检查的患者总体复发率明显低于引入前接受腹腔镜检查的患者(18.6%对 33.1%,相对风险 0.56,95%CI 0.32-0.97,P<0.05)。
术后 OC 使用可降低腹腔镜切除卵巢子宫内膜异位症后复发的风险。这些信息将有助于术前和术后管理的合理规划。